Multicomponent therapeutics for networked systems
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“combinations of chemical agents (or manipulations such as those of transcription factors that affect multiple steps in a pathway [1906] or modulation of multiple gene products [2311], or both [2312,2313]) will be far more efficacious, for instance in modulating iron-catalysed oxidative stress and its sequelae, than will be the use of 'magic bullet' single agents.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1705]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“There have been attempts to systematize a set of principles that can account for combination drugs that exist toda”
BackgroundLessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundBlume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Transcriptional Regulatory Networks in Saccharomyces cerevisiae
Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., Harbison, C. T., Thompson, C. M., Simon, I., et al. (2002) · Science · doi:10.1126/science.1075090 · Cited by 2,956
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419 · cited 1×
“Numerous researchers have attempted to provide an unambiguous framework for the calculation of additive effects between compounds; these approaches are reviewed comprehensively elsewher”
BackgroundSystematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Self-citation
Research works printed but not linked: 2
- Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet 2, 445–451 (1913).
- Albert, A. Selective Toxicity (Methuen & Co., London, 1968).
Cited by
Items 601–700 of 799
Manimaran, D., Tessema, A., Yadav, M. G., Parthasarathi, S., & Palanisamy, V. (2025) · Biochemistry Research International · doi:10.1155/bri/9599942 · Cited by 4
Podichetty, V. K., Weshler, & Schlosser (2011) · Nutrition and Dietary Supplements · doi:10.2147/nds.s18097 · Cited by 4
Enzymatic Synthesis of Ascorbic Acid-Ketone Body Hybrids
Venturi, V., Lerin, L. A., Presini, F., Giovannini, P. P., Catani, M., Buratti, A., Marchetti, N., Dilliraj, L. N., & Aprile, S. (2023) · Catalysts · doi:10.3390/catal13040691 · Cited by 4
Ebrahimi, M., Firuzi, O., Miri, R., Razzaghi‐Asl, N., & Ebadi, A. (2016) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-016-0197-0 · Cited by 4
Strategies for Multi-Target Directed Ligands: Application in Alzheimer’s Disease (AD) Therapeutics
Das, S., & Basu, S. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_8 · Cited by 4
Kurniawan, S. N., Utomo, D. H., Rudijanto, A., Rahayu, M., & Aulanni’am, A. (2018) · International Journal Bioautomation · doi:10.7546/ijba.2018.22.2.159-168 · Cited by 4
Amir, M., Alam, A., Ishrat, R., Alajmi, M. F., Hussain, A., Rehman, M. T., Islam, A., Ahmad, F., Hassan, M. I., & Dohare, R. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0072 · Cited by 4
Strategies of Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_2 · Cited by 6
de Diego, A. M. G., Lorrio, S., Hernández-Guijo, J. M., Gandía, L., & de Diego, A. M. G. (2012) · Wiley eBooks · doi:10.1002/9781118185537.ch4 · Cited by 4
Wang, S., Fu, P., Liu, L., Wang, L., Peng, C., Zhang, W., & Liu, R. (2016) · RSC Advances · doi:10.1039/c6ra01382a · Cited by 4
An ethnopharmacological study of plants used for treating respiratory infections in rural Maputaland
York, T. (2012) · Cited by 7
Introduction: The Case for Polypharmacology
Hopkins, A. L. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch · Cited by 6
Preventing Preterm Birth: The Search for Tocolytic Synergism
Hossain, M. R., Paul, M., Tolosa, J. M., Smith, R., & Paúl, J. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01941-4 · Cited by 4
Phasaludeen, B., Sheffield, H., Pancholi, K., Bharathan, G., Darwich, D. M., Khan, H., Mudgil, P., Habib, I., Huber, L., Buhr, R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-48079-0 · Cited by 3
“In contrast, syncretic synergy occurs when one compound lacks antimicrobial properties but amplifies the antimicrobial effectiveness of the other 44 .”
SİNERJİSTİK İLAÇ KOMBİNASYONLARININ ANALİZİNDE GÜNCEL MATEMATİKSEL VE İSTATİSTİKSEL YÖNTEMLER
ÖZER, B. O. (2023) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1180259 · Cited by 3
Duan, X. W., Wang, X., Li, Z., Liu, C., Zhang, L., Bao, Y., Shi, W., & Zhao, X. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1445216 · Cited by 3
Shi, H., Li, J., Hao, Y., & Sun, Y. (2018) · International Journal Bioautomation · doi:10.7546/ijba.2018.22.2.169-178 · Cited by 3
Database Resources for Drug Discovery
Kumar, A., & Arya, P. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-6815-2_5 · Cited by 4
Personalized Treatments: Where Patient’s History and Biological Background Meet
Bizzarri, M., Pensotti, A., Cucina, A., Monti, N., & Fedeli, V. (2022) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-74804-3_4 · Cited by 3
Mishra, R. K., Mishra, A., & Gupta, A. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00484 · Cited by 3
Shin, S., & Nguyen, L. K. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3008-2_17 · Cited by 3
Díaz-Herrera, T. H., Caldas, M. L., & Coy-Barrera, E. D. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072275982231230073813 · Cited by 3
Song, Y., Ke, Y., Lin, L., & Zhao, M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104618 · Cited by 3
Rahman, M. M., Uddin, M. S., Nejum, M. R., Din, S., & Uddin, G. M. S. (2016) · Planta · doi:10.11648/j.plant.s.2017050501.12 · Cited by 3
“Search of new drugs is an increasing incidence in many researches due to the adverse side effect associated with conventional drugs, resistant to antibiotics and to combat the multi-resistant microorganism [9-12].”
BackgroundNanoscale Delivery Systems for Combination Chemotherapy
Liboiron, B. D., Tardi, P. G., Harasym, T. O., & Mayer, L. D. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch31 · Cited by 5
Peng, W., Gao, F., Jiang, Y., Yang, H., Gan, Y.-X., Lu, J., Fu, C., & Li, P. (2015) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v12i5.6 · Cited by 3
“The curative effect of a single medicine may not be strong because of the complex pathogenesis and progression of diseases, and various side effects of a single medicine may also block its application (Keith et al., 2005).”
BackgroundA Novel Classification Method for Class-imbalanced Data and Its Application in microRNA Recognition
Geng, X., Zhu, Y., & Yang, Z. (2018) · International Journal Bioautomation · doi:10.7546/ijba.2018.22.2.133-146 · Cited by 3
Halder, A. K., Moura, A. S., & Cordeiro, M. N. D. S. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_14 · Cited by 4
Kumara, H. K., Ramesh, S., Vardhan, D. M. S., Shobha, M., & Gowda, D. C. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.027 · Cited by 3
Borisy, A. A., Zimmermann, G. R., & Lehár, J. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch15 · Cited by 4
Self-citationSalicylic Acid Polymers in Periodontal Tissue Healing
Graves, D. T., Cao, Y., Coelho, P. G., Witek, L., & Uhrich, K. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_4 · Cited by 3
The Optimal Design of Pharmacological Experiments
Kenakin, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813957-8.00008-4 · Cited by 3
Chen, H., Fianu, F., Moraru, C. I., Yang, R., & Cheng, Y. (2024) · Advanced Materials Interfaces · doi:10.1002/admi.202400287 · Cited by 2
Synthesis and Antimicrobial Activity of Benzo[H][1,6]Naphthyridine Derivatives
Raghunath, B. T., Balasaheb, P. P., Satish, M. C., Pratiksha, G., & Vasant, M. P. (2016) · Journal of Organic & Inorganic Chemistry · doi:10.21767/2472-1123.100009 · Cited by 2
Berko, Y. A., & Akala, E. O. (2020) · Pharmaceutical Nanotechnology · doi:10.2174/2211738508666200224110410 · Cited by 2
Nanomedicine-Based Combinational Therapy for Breast Cancer
Jain, P., Hassan, N., Farooq, U., Mohapatra, S., Alex, T. S., Fatima, M., Mirza, M. A., & Iqbal, Z. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_9 · Cited by 2
Šturm, L., Črnivec, I. G. O., Prislan, I., & Ulrih, N. P. (2023) · Molecules · doi:10.3390/molecules28020712 · Cited by 2
Mixed Messages: How Bacteria Resolve Conflicting Signals
Young, J. W., & Elowitz, M. B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.005 · Cited by 2
“Finally, there is increasing excitement about the prospects of combinatorial therapies in pharmaceutical development (Keith et al., 2005).”
BackgroundIdentification of combination therapy models using a neuro fuzzy identification scheme
Giotis, T., Christodoulou, M. A., & Boutalis, Y. (2011) · Mediterranean Conference on Control and Automation (MED) · doi:10.1109/med.2011.5983229 · Cited by 2
“[1], [2], [3], [4] This paper is divided in three parts.”
BackgroundMethodInfluentialIn vitro antimicrobial activity of cefsulodin and kanamycin in combinations
Maity, S. N., Chintaparthi, M., Hima, M. A., Kanta, R. C., & Kapur, I. (2014) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20140557 · Cited by 2
Computer Aided Multi-target Drug Design, Multi-target Virtual Screening
Xiao, H., Shi, Z., Tan, C., Jiang, Y., Go, M., Low, B. C., & Chen, Y. (2010) · Cited by 2
Network Pharmacology in the Study of TCM Formulae
Zhao, J., Nagle, D. G., Zhou, Y., & Zhang, W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812744-5.00004-7 · Cited by 4
Kumar, S., & Peterson, T. R. (2019) · Nutrition and Healthy Aging · doi:10.3233/nha-190064 · Cited by 2
“Using synergistic combinations has the potential to lower the amount of each agent one has to use, which should be beneficial in lowering their potential side effects [29, 30].”
BackgroundDimpfel, W., Seilheimer, B., & Schombert, L. (2019) · Neuroscience & Medicine · doi:10.4236/nm.2019.104030 · Cited by 2
Bizzarri, M., Minini, M., & Monti, N. (2020) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-32857-3_1 · Cited by 2
Lessa, R. C. D. S. (2020) · Revista Virtual de Química · doi:10.21577/1984-6835.20200132 · Cited by 3
Network Pharmacology and Modern Drug R&D Cases
Zhang, W., & Zhao, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-0753-0_6 · Cited by 3
Magic bullets: Drug repositioning and drug combinations
Yella, J., & Jegga, A. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00116-x · Cited by 2
Huang, X., & Chen, D. Y. ‐. (2022) · Wiley eBooks · doi:10.1002/9781119627784.ch14 · Cited by 2
Polypharmacology in Clinical Applications—Anti-inflammation Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_11 · Cited by 2
Zhang, Q., Chen, D., Guixiang, Z., Shihu, Z., Xiao, F., Chaoqun, M. A., & Yi, Z. (2024) · PubMed Central · doi:10.19852/j.cnki.jtcm.20231110.006 · Cited by 2
5-Fluorouracil/Coumarin and 5-Fluorouracil/Chromone Hybrids: Synthesis and Drug-Likeness Modeling
Giraldo-Arroyave, L., Yepes, A. F., & Cardona‐Galeano, W. (2024) · Molbank · doi:10.3390/m1779 · Cited by 2
“Hybrid molecules bear two distinct pharmacophores with different biological functions [16–19].”
BackgroundPartialFibers: An Efficient Method for Predicting Drug-Drug Interactions
Bumin, A., Huang, K., & Kahveci, T. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-82768-6_3 · Cited by 2
“This is because, a synergic drug combination accesses context specific multi-target mechanisms, and makes it harder for a cancer cell to develop resistance to multiple mechanisms of action [14].”
Ndhlala, A. R. (2009) · ResearchSpace (University of KwaZulu-Natal) · Cited by 5
Mulder, W. D., Kuiper, M. T. R., & Flobak, Å. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/630616 · Cited by 2
“Consequently, our reference model reduces to the Bliss independence model for three drugs in this special case, since the special case implies that gi = fi by (10).”
BackgroundMethodInfluentialPaul, R. K., Sengupta, S., Roy, D., Sarkar, D., Biswas, S., Dasgupta, D., Mariappan, G., Alam, F., & Nag, M. (2025) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-024-03282-5 · Cited by 1
Thermodynamic Perspectives on the Impact of a Second Drug on Amorphous Drug Solubility
Kaneko, S., Ueda, K., Hakata, R., Higashi, K., Ito, M., Noguchi, S., & Moribe, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00345 · Cited by 1
Benhacene, W., Cherrada, N., Zekhemi, Z., Souttou, S., Rezik, K. N., Benabdesselam, R., Aziz, T. A., Shami, A., Alwethaynani, M. S., Al‐Joufi, F. A., et al. (2026) · Open Chemistry · doi:10.1515/chem-2025-0222 · Cited by 1
“…metabolic syndrome ’ s complex, multifactorial nature and may explain the extract ’ s superior e ffi cacy compared to single-compound interventions [95, 96] emphasized that synergistic anti-in fl ammatory e ff ects occur when multiple phytochemicals work together, suggesting our extract ’ s complex…”
Herrera‐Ramírez, A., Becerra-Quintana, R., Yepes, A. F., & Cardona‐Galeano, W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344602 · Cited by 1
Bobtaina, E., & Ölgen, S. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2679002 · Cited by 1
Considerations on combination therapies for disease modification in Parkinson’s
Hughes, R. M., Pilcicka, A., Klee, T., Ducotterd, F., Mortiboys, H., & Stott, S. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01483-9 · Cited by 1
“Pharmacologically, combination therapies can be divided into different basic subtypes - congruous, syncretic, and coalistically additive 8,16 .”
Hussein, H. A., Borrel, A., Regad, L., Flatters, D., Badel, A., Geneix, C., Petitjean, M., Camproux, A., & Taboureau, O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00017-1 · Cited by 2
Epistructure-Based Design of Drugs with Controlled Promiscuity
Fernández, A. (2016) · Soft and biological matter · doi:10.1007/978-3-319-30852-4_13 · Cited by 1
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00011-8 · Cited by 1
Systems Biology Analysis of Kinase Inhibitor Protein Target Profiles in Leukemia Treatments
Colinge, J., Rix, U., Bennett, K. L., & Superti‐Furga, G. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-28792-3_9 · Cited by 1
A “Magic Shotgun” Perspective on Anticonvulsant Mechanisms
Bianchi, M. T., & Chuang, K. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch10 · Cited by 1
Odima, C. A., Ubani, C. S., Eze, E. A., Oje, O. E., Agu, E. C., & Joshua, P. E. (2014) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 1
Application of Graph-Based Analysis of Genomic Sequence Context for Characterization of Drug Targets
Pančoška, P. (2006) · Current Drug Discovery Technologies · doi:10.2174/157016306780136808 · Cited by 1
Aly, E. I. (2011) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2011.07.004 · Cited by 1
A Network Target-based Approach for Evaluating Multicomponent Synergy
Li, S., Ningbo, Z., & Zhang, B. (2010) · Cited by 1
Neuromodulatory Role of Withania somnifera
Kaur, G., Kaur, T., Gupta, M., & Manchanda, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_20 · Cited by 5
Do Ayurveda drugs induce liver injury?
Ruknuddin, G. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i3.400 · Cited by 1
Application of a Microfluidic Chip with Mechanical Stimuli for Culturing Mouse Embryos in vitro
Li, J., Li, Q., Wei, G., Liu, B., Zhang, J., & Li, Y. (2018) · International Journal Bioautomation · doi:10.7546/ijba.2018.22.2.107-116 · Cited by 1
Mancheva, K., Stephanova, D. I., Wolf, W., Institut für Infomationstechnik, U. D. B. M., & Kossev, A. (2018) · International Journal Bioautomation · doi:10.7546/ijba.2018.22.2.187-194 · Cited by 1
In-Silico Methodologies for Cancer Multidrug Optimization
Hasan, D. M., Eldin, A. S., Khedr, A. E., & Fahmy, H. A. (2018) · INTERNATIONAL JOURNAL OF COMPUTERS & TECHNOLOGY · doi:10.24297/ijct.v17i2.7168 · Cited by 2
DNA complexes as an efficient gene anticancer drug delivery therapy
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00020-2 · Cited by 1
Multi-parametric characterization of drug effects on cells
Paran, Y., Liron, Y., Batsir, S., Mabjeesh, N. J., Geiger, B., & Kam, Z. (2020) · F1000Research · doi:10.12688/f1000research.26254.2 · Cited by 1
“Redundan-cies and multi-functionalities in molecular networks mediating cellular mechanisms 60–62 and the multi-genetic nature of diseases such as cancer, with abnormal protein interactions and modified cellular mechanisms, suggest a potential for the discovery and optimization of…”
BackgroundMethodNovotný, B., Nagy, M., & Kurin, E. (2021) · Pharmaceutical Statistics · doi:10.1002/pst.2118 · Cited by 1
“Using formula (10), one can calculate “exact” combination index CI(xA, xB) for any dose pair (xA, xB).”
MethodMorales, D. L. S. (2017) · Organic and Medicinal Chemistry International Journal · doi:10.19080/omcij.2017.01.555569 · Cited by 1
Analysis of floor stability in underground coal mines
Santos, C. A. (1988) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 1
Li, R., Zou, X., Luan, P., Liu, X., Wang, N., Wang, Q., Guan, H., & Xu, Z. (2022) · Analytical Letters · doi:10.1080/00032719.2022.2053700 · Cited by 1
“Fortunately, the limitations of single-target therapy for multifactorial diseases may be overcome by suppressing the pathogenetic mechanisms on multiple fronts (Keith, Borisy, and Stockwell 2005).”
BackgroundWang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_1 · Cited by 1
Бобров, Е. С., Gorbunova, A. Y., Sannikova, E. P., Gubaidullin, I. I., Ignatova, O. M., Kopaeva, M. Y., Bulushova, N. V., & Kozlov, D. G. (2022) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683822090034 · Cited by 1
Screening combinatorial perturbations via a bifurcation-based method
Liu, L., Chen, Q., & Wang, R. (2022) · Modern Physics Letters B · doi:10.1142/s0217984922500178 · Cited by 1
Kaplan, Ö. (2023) · Journal of Scientific Reports-A · doi:10.59313/jsr-a.1347817 · Cited by 1
“The integration of the median-effect equation grounded in the mass action law has accelerated its practical applications [33, 34].”
BackgroundEl‐Deeb, N. M., Ibrahim, O. M., Kamel, A., Gomaa, A. I., & Kenawy, A. M. A. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04772-7 · Cited by 1
“There is growing enthusiasm for the utilization of combination therapy [46–51], because of the expected greater selectivity than the traditional methods [47, 52].”
Hasan, M. S. A., Emon, Y., Alshahrani, M. Y., Rakib, I. H., Mia, E., Sultana, A., Hasan, A., & Islam, M. T. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04538-5 · Cited by 2
“This approach reduces adverse effects by lowering individual drug doses (Keith et al. 2005).”
Computational Systems Biology Approaches for Deciphering Traditional Chinese Medicine
Li, S., & Lu, L. (2013) · Springer eBooks · doi:10.1007/978-3-642-38951-1_11 · Cited by 1
High-Throughput Biologically Optimized Search Engineering Approach to Synthetic BiologyPreprint
Valente, A. X. C. N., & Fong, S. S. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1103.5490 · Cited by 2
“rget is unnecessarily restrictive. Instead, the single drug magic-bullet could be beneficially replaced by the multi-compound drug cocktail, that synergistically acts at multiple points of the system (26; 27). But direct design of a drug cocktail is too difficult while, akin to the DS of Synthetic Biology, the Cocktai…”
BackgroundCombinatoRx brings its molecular speed dating to Singapore
Frank, M. G., & Altmeyer, R. M. (2007) · Biotechnology Journal · doi:10.1002/biot.200700113 · Cited by 1
Motility Contrast Imaging and Tissue Dynamics Spectroscopy
Nolte, D. D., An, R., & Turek, J. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-06419-2_38 · Cited by 1
“Phenotypic profiling, on the other hand, presents a systems-biology approach that has more biological relevance by capturing multimodal influence of therapeutics [67].”
BackgroundKashif, M. (2015) · Uppsala University Publications (Uppsala University) · Cited by 1
Falconer, S. B. (2014) · MacSphere (McMaster University) · doi:10.71548/19520 · Cited by 1
Systems Pharmacology in Cancer
Yu, Q., & Liu, E. T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-372550-9.00016-x
Systems Pharmacology, Biomarkers, and Biomolecular Networks
Adourian, A. S., Plasterer, T. N., Balasubramanian, R., Jennings, E. G., Wang, S., Martin, S. A., van der Greef, J., McBurney, R. N., Muntendam, P., & Afeyan, N. B. (2008) · Wiley eBooks · doi:10.1002/9780470431818.ch4
A Novel High-Throughput Screening Tool in Saccharomyces Cerevisiae
Coorey, N. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17004727
Paudel, N. (2014) · DSpace@MIT (Massachusetts Institute of Technology)
Discovery of Predictive Biomarkers for Anticancer Drugs
Neve, R. M., Belmont, L. D., Bourgon, R., Evangelista, M., Huang, X., Schmidt, M., Yauch, R. L., & Settleman, J. E. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677252.ch02 · Cited by 1
Metadata
- Authors
- Keith, C. T., Borisy, A. A., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Corresponding author
- Keith, Curtis T.
- Borisy, Alexis A.
- Stockwell, Brent R.
- ORCID
- Stockwell, Brent R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-01
- Volume
- 4
- Issue
- 1
- Pages
- 71-78
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1592483428
- Cited by
- 769
- References
- 67
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 30 · 2023: 33 · 2022: 44 · 2021: 36 · 2020: 34 · 2019: 36 · 2018: 42 · 2017: 29 · 2016: 43 · 2015: 51 · 2014: 55 · 2013: 49 · 2012: 47
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- combination therapy, systems biology, mechanism of action, drug discovery
- MeSH terms
- Clinical Trials as Topic, Drug Synergism, Drug Therapy, Combination, Humans, Terminology as Topic, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.